John N. Constantino is a board-certified child and adolescent psychiatrist and chief of behavioral and mental Health at Children’s Healthcare of Atlanta, as well as professor of psychiatry and pediatrics at Emory University School of Medicine. He is an international leader in autism trait phenotyping, sex differences in autism, and endophenotypic analyses.
John Constantino
Chief of behavioral and mental health
Children’s Healthcare of Atlanta
From this contributor
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024
6 min read
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024 | 6 min read
Q&A with John Constantino: Solving the biomarker conundrum
Biological factors that reflect autism’s roots may differ from those that influence how severe the condition is. Failure to make a distinction has stymied the search for biomarkers.
Q&A with John Constantino: Solving the biomarker conundrum
By
Alla Katsnelson
3 August 2021 | 7 min read
Traits of other conditions may spur autism
Early features of other conditions may contribute to autism itself
Traits of other conditions may spur autism
By
John Constantino, Zoë Hawks
12 June 2018 | 7 min read
Japanese spectrum
Researchers studying autism prevalence should take into account the continuous nature of autism symptoms in the general population, says John Constantino.
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
By
Chand Chandrasekaran
20 April 2026 | 6 min read
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read